03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Binosto : | |
Type | Medicine Authorised |
Originator | Fosamax Once Weekly |
Agent | Levant Alie Houses |
Distributor | Levant Alie Houses |
Laboratory | Labatec Pharma |
Responsible Party | Labatec Pharma SA |
Origin | Switzerland |
Manufacturer | SwissCo Services AG |
Manufacturing Type | G |
Origin | Switzerland |
ATC | M05BA04 |
Binosto :
Binosto :
Binosto :
Binosto :
Binosto :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Binosto :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Abdominal bloating (Meteorism) | Common |
Abdominal pain | Common |
Alopecia | Common |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Rare |
Asthenia | Common |
Cephalea | Common |
Constipation | Common |
Diaphyseal femoral fractures | Rare |
Diarrhoea (Diarrhea) | Common |
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) | Uncommon |
Dyspepsia | Common |
Dysphagia | Common |
Episcleritis | Uncommon |
Erythema | Uncommon |
Esophageal erosions | Uncommon |
Fever | Uncommon |
Flatulence | Common |
Gastritis | Uncommon |
Gastrointestinal bleeding | Rare |
Gastrointestinal perforation | Rare |
Gastrointestinal ulcer | Rare |
Hypersensitivity reactions | Rare |
Hypocalcaemia | Rare |
Joint swelling | Common |
Lightheadedness | Common |
Lyell Syndrome (Toxic epidermal necrolysis) | Rare |
Malaise | Uncommon |
Melaena | Uncommon |
Myalgia | Very Common |
Nausea | Uncommon |
Oedema peripheral | Common |
Oesophageal acid reflux | Common |
Oesophageal stenosis | Rare |
Oesophageal ulcer | Common |
Oesophagitis | Uncommon |
Osteoarticular pain | Very Common |
Osteonecrosis of the jaw | Rare |
Pharyngeal ulceration | Rare |
Photosensitivity | Rare |
Pruritus | Common |
scleritis | Uncommon |
Skin rash | Uncommon |
Skin reaction | Rare |
Stevens-Johnson syndrome | Rare |
Subtrochanteric femoral fractures | Rare |
Urticaria | Rare |
Uveitis | Uncommon |
Vertigo | Common |
Vomiting | Uncommon |
Binosto :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Binosto MoH 10079 :
Form | Tablet, Effervescent |
Package Size | Box of 4 |
Strength | 70mg |
Public Price | 1709367.66 L.L. |
Stratum | B |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 103119/1 |
Submission date | 25/06/2019 |
Registration Year | 24/09/2019 |
Price Comparison
● Country: | Switzerland | |
● Package Size: | 4 | |
● Public Price: | 41 CHF | ( 4,240,220.00 LBP ) |
● Pack size unit used: | 4 | |
● Cost/Unit: | 10,25 CHF | ( 1,034,200.00 LBP ) |
● Exfactory Price: | 21.43 CHF | |
● Pricing Date: | 04/04/2021 | |
● Type: | Medicine Authorised |
● Country: | Bahrain | |
● Package Size: | 4 | |
● Public Price: | 13.76 BHD | ( 3,271,219.84 LBP ) |
● Pack size unit used: | 4 | |
● Cost/Unit: | 3,44 BHD | ( 713,202.00 LBP ) |
● Reference: | nhra | |
● Pricing Date: | 09/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Germany | |
● Package Size: | 4 | |
● Public Price: | 27.08 EUR | ( 2,623,402.08 LBP ) |
● Pack size unit used: | 4 | |
● Cost/Unit: | 6,77 EUR | ( 581,256.00 LBP ) |
● Pricing Date: | 15/05/2021 | |
● Type: | Medicine Authorised |
● Country: | Norway | |
● Package Size: | x4stk | |
● Public Price: | 250.8 NOK | ( 2,032,483.20 LBP ) |
● Pack size unit used: | 4 | |
● Cost/Unit: | 62,7 NOK | ( 502,448.00 LBP ) |
● Pharmacy Price: | 168.24 NOK | ( 1363416.96 LBP ) |
● Reference: | Norwegian Medicine Agency | |
● Pricing Date: | 01/04/2020 | |
● Type: | Medicine Authorised |
● Country: | Ireland | |
● Package Size: | 4 | |
● Public Price: | 21.21 EUR | ( 2,054,739.96 LBP ) |
● Pack size unit used: | 4 | |
● Cost/Unit: | 5,3025 EUR | ( 484,380.00 LBP ) |
● Exfactory Price: | 20 EUR | |
● Pricing Date: | 09/10/2020 | |
● Type: | Medicine Authorised |
● Country: | UK | |
● Package Size: | 4 | |
● Public Price: | 18 GBP | ( 2,045,682.00 LBP ) |
● Pack size unit used: | 4 | |
● Cost/Unit: | 4,5 GBP | ( 454,596.00 LBP ) |
● Reference: | DMD | |
● Pricing Date: | 08/03/2021 | |
● Type: | Medicine Authorised |
● Country: | Lebanon | |
● Form: | Tablet, Effervescent | |
● Package Size: | Box of 4 | |
● Public Price: | 1709367.66 LBP | ( 1,709,367.66 LBP ) |
● Pack size unit used: | 4 | |
● Cost/Unit: | 427341,92 LBP | ( 427,341.00 LBP ) |
● Pricing Date: | 13/06/2024 |
● Country: | Qatar | |
● Package Size: | 4 | |
● Public Price: | 68 QAR | ( 1,669,944.00 LBP ) |
● Pack size unit used: | 4 | |
● Cost/Unit: | 17 QAR | ( 417,486.00 LBP ) |
● Pharmacy Price: | 55.39857648 QAR | ( 1360478.2411958 LBP ) |
● Pricing Date: | 28/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Italy | |
● Package Size: | 4 | |
● Public Price: | 16.18 EUR | ( 1,567,453.68 LBP ) |
● Pack size unit used: | 4 | |
● Cost/Unit: | 4,045 EUR | ( 387,504.00 LBP ) |
● Pricing Date: | 17/12/2019 | |
● Type: | Medicine Authorised |
● Country: | Abu Dhabi | |
● Package Size: | 4 Effervescent tablets | |
● Public Price: | 66.5 AED | ( 1,606,706.50 LBP ) |
● Pack size unit used: | 4 | |
● Cost/Unit: | 16,625 AED | ( 386,576.00 LBP ) |
● Pharmacy Price: | 53.68 AED | ( 1296962.48 LBP ) |
● Pricing Date: | 27/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Jordan | |
● Package Size: | 4 | |
● Public Price: | 14.99 JOD | ( 1,877,062.79 LBP ) |
● Pack size unit used: | 4 | |
● Cost/Unit: | 3,7475 JOD | ( 375,663.00 LBP ) |
● Pharmacy Price: | 11.44 JOD | ( 1432528.24 LBP ) |
● Reference: | JFDA | |
● Pricing Date: | 02/01/2021 | |
● Type: | Medicine Authorised |
● Country: | Kuweit | |
● Package Size: | 70mg | |
● Public Price: | 6.5 KWD | ( 1,908,276.50 LBP ) |
● Pack size unit used: | 4 | |
● Cost/Unit: | 1,625 KWD | ( 293,581.00 LBP ) |
● Pharmacy Price: | 5.49 KWD | ( 1611759.69 LBP ) |
● Pricing Date: | 07/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Cyprus | |
● Package Size: | 4 TABS | |
● Public Price: | 14.7 EUR | ( 1,424,077.20 LBP ) |
● Pack size unit used: | 4 | |
● Cost/Unit: | 3,675 EUR | ( 290,628.00 LBP ) |
● Reference: | Cyprus Minister of Health | |
● Pricing Date: | 24/03/2021 | |
● Type: | Medicine Authorised |
● Country: | Greece | |
● Package Size: | 4 | |
● Public Price: | 13.64 EUR | ( 1,321,388.64 LBP ) |
● Pack size unit used: | 4 | |
● Cost/Unit: | 3,41 EUR | ( 290,628.00 LBP ) |
● Exfactory Price: | 9.44 EUR | |
● Pharmacy Price: | 9.9 EUR | ( 959072.4 LBP ) |
● Reference: | National Organization for Medicines | |
● Pricing Date: | 25/02/2021 | |
● Type: | Medicine Authorised |
● Country: | Spain | |
● Package Size: | 4 | |
● Public Price: | 10.51 EUR | ( 1,018,166.76 LBP ) |
● Pack size unit used: | 4 | |
● Cost/Unit: | 2,6275 EUR | ( 193,752.00 LBP ) |
● Reference: | Agencia Española de Medicamentos y Productos Sanitarios | |
● Pricing Date: | 06/05/2021 | |
● Type: | Medicine Non Marketed |
● Country: | KSA | |
● Package Size: | 4 | |
● Public Price: | 28.5 SAR | ( 673,740.00 LBP ) |
● Pack size unit used: | 4 | |
● Cost/Unit: | 7,125 SAR | ( 165,480.00 LBP ) |
● Reference: | sfda | |
● Pricing Date: | 05/03/2020 | |
● Type: | Medicine Non Marketed |
Note
You have to register to view this info
Drop File